Cook's New Chef Tries a Different Recipe
Executive SummaryTop management changes at Cook are bringing subtle shifts in the company's attitude towards the marketplace. John DeFord, who has been at the company for 15 years is now president and CEO of its interventional products business, replacing Phyllis McCollough, who moves up to Chairman and EVP of operations for all of Cook Group. DeFord is spearheading Cook's new, more aggressive, opportunistic approach. A noteworthy example: Cook is embarking on a series of distribution deals with a competitor, stent market leader Guidant.
You may also be interested in...
Japanese firm in discussions with regulator as high-need novel therapy for spinocerebellar degeneration misses endpoint but shows promise in pooled analysis.
The FDA has readied plans for hastened emergency-use approvals of coronavirus test kits after an infected US citizen returned to Washington State from Wuhan province in China. See what the FDA’s Megan McSeveney said about it here.